Neurosterix
Geneva
About Neurosterix
Neurosterix aims to create novel medicines based on allosteric modulation that overcome the limitations of traditional treatments and have the potential to significantly enhance patients' lives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $65.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2024)
- Website: neurosterix.com
- Phone: [email protected]
Industries & Categories
Biopharma, Health Care, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neurosterix-54496 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.